This article has been updated from a previous version to correct the spelling of Lakshmi Sundaram's name.

By Ben Butkus

A new molecular point-of-care test for African sleeping sickness being developed by the Foundation for Innovative New Diagnostics and Japanese clinical diagnostics firm Eiken Chemical has entered clinical field trials, FIND said this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.